Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: A Trans-Tasman Radiation Oncology Group study

International Journal of Radiation Oncology Biology Physics

Volumn 51, Issue 1, 2001, Pages 156-163

  Poulsen, Michael ^a   Rischin, Danny ^b   Walpole, Evan ^c   Harvey, Jennifer ^a   Macintosh, John ^d   Ainslie, Jill ^b   Hamilton, Chris ^e   Keller, Jacqui ^a   Tripcony, Lee ^a  

^a Queensland Radium Institute   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d MATER HOSPITAL   (Australia)

^e NEWCASTLE MATER HOSPITAL   (Australia)

Author keywords

Chemoradiotherapy; Merkel cell carcinoma; Toxicity

Indexed keywords

BIOLOGICAL MEMBRANES; CELLS; CHEMOTHERAPY; RADIOTHERAPY; SKIN; SURGERY; TOXICITY;

MOIST DESQUAMATION;

ONCOLOGY;

CARBOPLATIN; ETOPOSIDE;

ADULT; AGED; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER LOCALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; FEVER; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MALE; MERKEL CELL TUMOR; MINIMAL RESIDUAL DISEASE; MULTICENTER STUDY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT DISEASE; RISK FACTOR; SEPSIS; SKIN EXFOLIATION; SKIN TOXICITY; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, MERKEL CELL; COMBINED MODALITY THERAPY; ETOPOSIDE; FEASIBILITY STUDIES; FEMALE; FEVER; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIODERMATITIS; RADIOTHERAPY DOSAGE; SKIN NEOPLASMS;

EID: 0035450860     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01577-2     Document Type: Article

References (25)

1. Early aggressive treatment of merkel cell carcinoma improves outcome
2. Further insights into the natural history and management of primary cutaneous neuroendocrine (merkel cell) carcinoma
3. An analysis of prognostic factors in cutaneous neuroendocrine carcinoma
4. The importance of post operative radiotherapy in the treatment of merkel cell carcinoma
5. The essential role of radiation therapy is securing locoregional control of Merkel cell carcinoma
6. The role of radiation therapy and chemotherapy in the treatment of merkel cell carcinoma
7. Cutaneous neuroendocrine (Merkel cell) carcinoma. A report of 35 cases
8. Merkel cell tumor: Clinical behaviour and treatment
9. Multimodality management of Merkel cell carcinoma
10. Chemotherapy for metastatic merkel cell carcinoma. Review of the M.D. Anderson Hospital's experience
11. Chemotherapy for patients with locally advanced or metastatic Merkel cell
12. The treatment of advanced Merkel cell carcinoma. A multimodality chemotherapy and radiation treatment approach
13. Merkel cell carcinoma: Diagnosis and treatment
14. Carboplatin dosage. Prospective evaluation of a simple formula based on renal function
15. Reporting results with cancer
16. Chemotherapy in neuroendocrine/merkel cell carcinoma of the skin and review of 204 cases
17. Trabecular (Merkel cell) carcinoma of the skin. Treatment of primary, recurrent and metastatic disease
18. The role of radiotherapy in the management of primary cutaneous neuroendocrine tumors: Experience of the Peter MacCallum Cancer Institute (Melbourne Australia)
19. Merkel cell carcinoma
20. Radiotherapy for merkel cell carcinoma of the skin of the head and neck
21. Merkel cell carcinoma of the skin
22. Merkel cell carcinoma
23. O.R.M.E. Management of Merkel cell tumor
24. The natural history and management of merkel cell carcinoma of the skin: A review of 22 patients treated at the Royal Marsden Hospital
25. Twice daily compared with once daily thoracic radiotherapy in limited small cell lung cancer treated concurrently with cisplatin and etoposide